新聞Intercell USA, Inc. merges with Vivalis.Valneva was created when the Austrian biotech Intercell merged with the French biotech Vivalis.
新聞Intercell USA, Inc. launches novel vaccine against Japanese Encephalitis.Professor Alexander von Gabain is the founder of several biotech companies, including Intercell AG, which registered and launched a novel vaccine against Japanese Encephalitis worldwide.
新聞Valneva SE acquired Intercell USA, Inc. on Jan 1st '13.Intercell USA was acquired by Valneva SE (Lyon, France) in May 2013 and has been operating as a fully owned subsidiary.
